Clinician's Roundtable

Host: Mark Nolan Hill, MD Guest: Craig Nichols, MD If detected in its early stages, we have great success in curing testicular cancer. What are our most effective screening measures? How should we instruct our patients to be vigilant with their own self-exams, or is this the best approach? Dr. Craig Nichols, medical director of lymphoma and testicular cancer research at Providence Portland Medical...

Host: Mark Nolan Hill, MD Guest: Jam Ghajar, MD, PhD Advances in diagnostics for traumatic brain injuries will soon allow us to evaluate these injuries immediately after they occur. With many of our troops suffering these injuries, the United States military is making a push to accelerate development of a new assessment device. Jamshid Ghajar, MD, PhD, president of the Brain Trauma Foundation, the...

Host: Mark Nolan Hill, MD Guest: Jam Ghajar, MD, PhD Traumatic brain injuries are a major cause for concern for our troops returning home from military conflicts abroad. The development of a new eye-tracking device, initiated and funded, in part, by the United States Department of Defense, will soon provide an immediate assessment of traumatic brain injuries. How might this device change the entir...

Host: Larry Kaskel, MD Guest: Roberta Greenspan Roberta Greenspan, president of SpecialDocs, Inc., discusses the process of converting a traditional medical practice to a concierge medical practice. Ms. Greenspan explains the growth trend of concierge medicine, and the non-economic motivations of physicians converting their practices to a concierge model. Host Larry Kaskel investigates the differe...

Guest: Ruben Toral Host Dr. Larry Kaskel speaks with Ruben Toral, a recognized leader in medical tourism and healthcare globalization, at the Healthcare Globalization Summit in Las Vegas. What surprises will patients typically encounter when they explore their healthcare options abroad? Can the American healthcare system learn from the presentation of medical care around the world? Mr. Toral exami...

Host: Larry Kaskel, MD Guest: Todd Park Todd Park, cofounder and Chief Athenista at AthenaHealth, one of the fastest growing web-based practice management and electronic medical record companies, joined host Larry Kaskel at the Health Summit in Las Vegas. Todd discussed his vision of the future medical landscape. Join us to find out how companies like AthenaHealth try to help doctors master the ev...

Host: Maurice Pickard, MD Guest: Benjamin Hippen, MD Dr. Benjamin Hippen speaks about the Iranian system that allows an individual's kidney to be sold by the donor, whom we can also think of as the vendor. Examination has shown that the recipients are on a level playing field and there is no tourism or fraud. The responsibility for recruiting potential vendors becomes separated from the responsibi...

Host: Maurice Pickard, MD Guest: Benjamin Hippen, MD Dr. Benjamin Hippen reviews the kidney transplantation policy failure in the United States. The cost is now 21 billion dollars in Medicare commitment to end-stage renal disease and 50 percent of those on the transplant waiting list will likely die before receiving an organ. This situation is getting worse by the day. Iran is the only country in...

Host: Bruce Bloom, DDS, JD Guest: Walter Stadler, MD Targeted and Individualized Therapies for Cancer. Where are we? What's on the horizon? Associate Dean of Clinical Research, Professor of Medicine and Director of the Genitourinary program at the University of Chicago Pritzker School of Medicine, Dr. Walter Stadler, cites the majority of patients struggling with the side effects - while grasping...

Host: Bruce Bloom, DDS, JD Guest: Walter Stadler, MD In 1971 Dr. Judah Folkman announced to the world that angiogenesis would be the Achilles heel of cancer-what's happened in the last 35 years? Dr. Walter M. Stadler, professor of medicine, director of Genitourinary Program, and associate dean of Clinical Research at the University of Chicago Medical Center joins host Dr. Bruce Bloom to fast forwa...

Host: Bruce Bloom, DDS, JD Guest: Walter Stadler, MD Associate Dean of Clinical Research, and professor of medicine and director of the genitourinary program at the University of Chicago Pritzker School of Medicine, Dr. Walter Stadler discusses his role in oversight of clinical research with your host, Dr. Bruce Bloom.

Host: Bruce Bloom, DDS, JD Guest: Walter Stadler, MD Host Dr. Bruce Bloom welcomes Dr. Walter Stadler, professor of medicine and director of the genitourinary program at the University of Chicago Pritzker School of Medicine. We are still working toward a highly effective treatment for hormone refractory prostate cancer. Could a paradoxical treatment with high-dose testosterone hold the key to a cu...

Host: Bruce Japsen Guest: Jeffrey Aronin, MBA At a time drug companies are looking for new answers when it comes to developing new products and having a difficult time, the pharmaceutical industry may be on the verge of a different tact: turning to physcians and their advocacy organizations. Jeffrey Aronin, president and CEO of Ovation Pharmaceuticals Inc. tells the Chicago Tribune's Bruce Japsen...

Host: Bruce Japsen Guest: Jeffrey Aronin, MBA It seems most drug-makers are making their biggest sales to doctors by pushing medicines for common conditions whether they be statins for cholesterol or proton pump inhibitors for heartburn. But drugs can actually take on blockbuster significance for specialized treatment groups where treatment options are limited. Jeffrey Aronin, president and CEO of...

Host: Bruce Japsen Guest: Jeffrey Aronin, MBA Not all drug companies are in pursuit of billion-dollar blockbuster drugs taken by millions of Americans. In fact, there are drugs treating rare conditions that wouldn't be sold on the market if not for a landmark piece of legislation known as the Orphan Drug Act, now 25 years old. Jeffrey Aronin, president and CEO of Ovation Pharmaceuticals Inc. tells...

Host: Larry Kaskel, MD Guest: Gerald Dorn, MD Should African American’s be treated with beta blockers to prevent heart failure? This has been a controversial question in the cardiovascular community. In this segment, Dr. Gerald Dorn of Washington University School of Medicine explains the biological mechanisms in which beta blockers offer protection from heart failure and what led him and his team...

Host: Michael Greenberg, MD Guest: Tangerine Brigham Dr. Michael Greenberg welcomes Tangerine Brigham, Deputy Director of Health for the San Francisco Department of Health and Director of "Healthy San Francisco," a landmark plan to provide health care to San Francisco's 73,000 uninsured city residents. Now available at multiple clinics across the city, this program is intended to give people a med...

Host: Leslie P. Lundt, MD Guest: Sandra Aamodt, PhD With a myriad of overlapping hormones and neurotransmitters involved, weight regulation is a complex task. While our bodies aim to stow away energy reserves for emergent times, our patients simultaneously try desperately to shed unwanted pounds. As Sandra Aamodt, PhD, author and former editor-in-chief of Nature Neuroscience , tells host Dr. Lesli...

Host: Leslie P. Lundt, MD Guest: Sandra Aamodt, PhD Our patients use their brains every moment of their lives. So do we! How well do you know your brain? You may be distressed at the answer. Dr. Sandra Aamodt, co-author along with Dr. Sam Wang of Welcome to Your Brain joins host Dr. Leslie Lundt to discuss common misconceptions about neurobiology.

Host: Leslie P. Lundt, MD Guest: Rama Maganti, MD Status epilepticus. What does that bring to mind? For most of us, we think of convulsions. But this is not always the case. Epileptologist Dr. Rama Maganti discusses nonconvulsive status epilepticus with host Dr. Leslie Lundt.

Host: Leslie P. Lundt, MD Guest: Stuart Vyse, PhD The American economic environment has drastically changed since the 1970s, and we now live in a world of material desire. Almost anything imaginable is available to purchase, and many of our patients choose to buy frivolities instead of spending their money wisely. How can understanding the psychology of debt help us to help them? Dr. Stuart Vyse w...

Host: Leslie P. Lundt, MD Guest: Stuart Vyse, PhD Over the last 30 years, debt, bankruptcy and now home foreclosures have risen to crisis proportions. In addition, the personal savings rate of Americans is at its lowest point since the Great Depression. What is wrong with us? Dr. Stuart Vyse will be discussing his latest book, Going Broke: Why Americans Can’t Hold on to their Money , with host Dr....

Host: Leslie P. Lundt, MD Guest: Dan Roam Tremendous leaps have been made in the science of vision giving us a better understanding of how we see. What do visual pathways teach us about the process of visual thinking? Host Dr. Leslie Lundt welcomes Dan Roam, author of The Back of the Napkin: Solving Problems and Selling Ideas with Pictures to discuss how we can use visual thinking techniques to im...

Host: Leslie P. Lundt, MD Guest: Dan Roam How can we communicate complex concepts to each other and our patients? Our guest today suggests using the back of a napkin. Dan Roam, author of The Back of the Napkin: Solving Problems and Selling Ideas with Pictures discusses with host Dr. Leslie Lundt how we can use visual thinking in our practices.

Host: Leslie P. Lundt, MD Guest: James Levenson, MD What is the latest on Sickle Cell Disease? Is pain the only issue in a sickle cell crisis? Dr. James Levenson joins host Dr. Leslie Lundt to discuss his research findings on sickle cell anemia.